Lobby organisation
PTC Therapeutics
Company · Health & pharma · HQ: United States · Transparency Register entry
As of 8 October 2026, PTC Therapeutics appears in 3 declared MEP meetings (3 different MEPs), most often with European People's Party.
In their own words
“Our mission at PTC Therapeutics has always been to build an integrated biopharmaceutical company based on our expertise in RNA biology. We have focused on discovering and developing novel oral treatments for patients with serious and life-limiting disorders. By targeting the processes that modulate RNA biology and affect protein production, we bring an innovative approach to drug discovery.”
Read the rest of the statementShow less of the statement
“We are focused particularly on the development of treatments for rare and neglected disorders.”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 3 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2025–2025. Bar length is relative to its busiest year (3 in 2025). All meetings were in one calendar year.
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 3 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 21 Mar 2025 | Adam Jarubas | Choroby rzadkie |
| 19 Mar 2025 | Eszter Lakos | Biotechnology policy |
| 19 Mar 2025 | Nicolás González Casares | Health |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.